Activity of gemcitabine plus capecitabine in patients with metastatic breast cancer refractory to anthracyclines and taxanes

被引：0
|
作者：
Andres, R [1 ]
Matordomo, JI [1 ]
Polo, E [1 ]
Alvarez, I [1 ]
Lara, R [1 ]
Saenz, A [1 ]
Isla, D [1 ]
Escudero, P [1 ]
Tres, A [1 ]
机构：
[1] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
360
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [31] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    Stemmler, H. J.
    diGioia, D.
    Freier, W.
    Tessen, H. W.
    Gitsch, G.
    Jonat, W.
    Brugger, W.
    Kettner, E.
    Abenhardt, W.
    Tesch, H.
    Hurtz, H. J.
    Roesel, S.
    Brudler, O.
    Heinemann, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (07) : 1071 - 1078
  • [32] Pilot study of gemcitabine (G) plus trastuzumab (H) in metastatic breast cancer patients with erb-2 overexpression previously treated with anthracyclines (A) and taxanes (T)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 169 - 169
  • [33] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    H J Stemmler
    D diGioia
    W Freier
    H W Tessen
    G Gitsch
    W Jonat
    W Brugger
    E Kettner
    W Abenhardt
    H Tesch
    H J Hurtz
    S Rösel
    O Brudler
    V Heinemann
    British Journal of Cancer, 2011, 104 : 1071 - 1078
  • [34] A Phase I Study of Capecitabine Combined with CPT-11 in Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
    Kashiwaba, Masahiro
    Inaba, Toru
    Komatsu, Hideaki
    Ishida, Kazushige
    Kawagishi, Ryoko
    Matsui, Yusuke
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Wakabayashi, Go
    ONCOLOGY, 2014, 86 (04) : 206 - 211
  • [35] A Pooled Analysis of Gemcitabine Plus Docetaxel Versus Capecitabine Plus Docetaxel in Metastatic Breast Cancer
    Seidman, Andrew D.
    Chan, Stephen
    Wang, Jin
    Zhu, Chao
    Xu, Cong
    Xu, Binghe
    ONCOLOGIST, 2014, 19 (05): : 443 - 452
  • [36] Capecitabine and trastuzumab: a phase II study in HER2-overexpressing metastatic breast cancer (MBC) patients pretreated with anthracyclines and/or taxanes
    Schaller, G
    Bangemann, N
    Gonsch, T
    Weber, J
    Kleine-Tebbe, A
    Conrad, B
    Klare, P
    Hindenburg, HJ
    Ruhmland, B
    Lakner, V
    Hinke, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S94 - S95
  • [37] Gemcitabine plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Dong, Ningning
    Wu, Yongdong
    Song, Chenxin
    Wang, Mingyu
    Jiao, Yue
    Zhang, Shutian
    JOURNAL OF BUON, 2020, 25 (03): : 1348 - 1353
  • [38] A combination of Capecitabine plus Gemcitabine in pretreated patients with metastatic breast cancer: What's the right schedule?
    Nardi, Mario
    Azzarello, Domenico
    Carboni, Rita
    Zavettieri, Maria
    Raffaele, Mario
    Mare, Marzia
    Giannicola, Rocco
    Panuccio, Vincenzo
    Falzea, Antonella
    Del Medico, Pietro
    ANNALS OF ONCOLOGY, 2004, 15 : 54 - 54
  • [39] Phase II study cisplatin plus gemcitabine (Gemzar) in antracycline, docetaxel and capecitabine-refractory metastatic breast cancer
    Semiglazova, Tatiana
    Filatova, Larisa
    ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
  • [40] A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Sunela, Kaisa
    Lehtinen, Ilari
    Joensuu, Heikki
    Sjostrom-Mattson, Johanna
    CLINICAL BREAST CANCER, 2006, 7 (05) : 401 - 405
12345